M. Fava

487 total citations
13 papers, 379 citations indexed

About

M. Fava is a scholar working on Pharmacology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, M. Fava has authored 13 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Clinical Psychology and 5 papers in Psychiatry and Mental health. Recurrent topics in M. Fava's work include Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). M. Fava is often cited by papers focused on Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). M. Fava collaborates with scholars based in United States and Italy. M. Fava's co-authors include Jerrold F. Rosenbaum, Karen E. Anderson, J F Rosenbaum, Sid Zisook, Andrew A. Nierenberg, Andrea B. Stone, Teri Pearlstein, Frederic M. Quitkin, Perry F. Renshaw and A. R. Guimaraes and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and FEBS Letters.

In The Last Decade

M. Fava

12 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Fava United States	6	224	110	103	79	49	13	379
Joshua D. Isen United States	12	184 0.8×	111 1.0×	67 0.7×	105 1.3×	54 1.1×	19	441
Costanza Andrisano Italy	10	187 0.8×	101 0.9×	98 1.0×	60 0.8×	59 1.2×	12	387
Candace N. White United States	8	199 0.9×	60 0.5×	119 1.2×	102 1.3×	50 1.0×	10	404
Elana M. Hoffman United States	8	167 0.7×	59 0.5×	45 0.4×	110 1.4×	33 0.7×	8	407
Christian Scharfetter Switzerland	8	96 0.4×	76 0.7×	126 1.2×	71 0.9×	39 0.8×	32	306
Paul S. Oliva United States	7	180 0.8×	65 0.6×	75 0.7×	48 0.6×	38 0.8×	8	462
Jules R. Dugré Canada	13	191 0.9×	103 0.9×	161 1.6×	43 0.5×	65 1.3×	34	472
Gabi Pitschel‐Walz Germany	8	192 0.9×	86 0.8×	426 4.1×	67 0.8×	64 1.3×	13	564
Aviva Gold United Kingdom	5	229 1.0×	119 1.1×	313 3.0×	59 0.7×	99 2.0×	8	470
Monte J. Phillips United States	12	111 0.5×	55 0.5×	41 0.4×	51 0.6×	56 1.1×	16	424

Countries citing papers authored by M. Fava

Since Specialization

Citations

This map shows the geographic impact of M. Fava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fava more than expected).

Fields of papers citing papers by M. Fava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fava. The network helps show where M. Fava may publish in the future.

Co-authorship network of co-authors of M. Fava

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fava. A scholar is included among the top collaborators of M. Fava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fava. M. Fava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Singh, J, Maggie Fedgchin, Ella Daly, et al.. (2014). P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study. European Neuropsychopharmacology. 24. S387–S388. 1 indexed citations

Leuchter, Andrew F., Ian A. Cook, Lauren B. Marangell, et al.. (2007). P.2.g.007 Biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD). European Neuropsychopharmacology. 17. S394–S395. 1 indexed citations

Fava, M., Stefano Ferroni, & Mario Nobile. (2001). Osmosensitivity of an inwardly rectifying chloride current revealed by whole‐cell and perforated‐patch recordings in cultured rat cortical astrocytes. FEBS Letters. 492(1-2). 78–83. 12 indexed citations

Fava, M., et al.. (2000). Fluoxetine versus sertraline and paroxetine in major depression: Long‐term changes in weight. International Journal of Gynecology & Obstetrics. 70(S3). 1 indexed citations

Fava, M., et al.. (1998). 342. Fluoxetine versus sertraline and paroxetine in major depression: Safety and efficacy in anxious and nonanxious subgroups. Biological Psychiatry. 43(8). S103–S103. 1 indexed citations

Fava, M., et al.. (1998). A comparison of symptoms following treatment interruption: Evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine. European Neuropsychopharmacology. 8. S171–S172. 1 indexed citations

Fava, M., James E. Rosenbaum, S. Hoog, William B. Krebs, & John Dillon. (1998). A comparison of symptoms following treatment interruption: Evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine. European Psychiatry. 13(S4). 204S–205S. 5 indexed citations

Fava, M., et al.. (1998). Fluoxetine versus sertraline and paroxetine in major depression: Long-term changes in weight. European Neuropsychopharmacology. 8. S204–S204. 5 indexed citations

Fava, M., Andrew A. Nierenberg, Frederic M. Quitkin, et al.. (1997). A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.. PubMed. 33(1). 101–3. 55 indexed citations

10.

Fava, M., et al.. (1995). Gender differences in personality disorders. American Journal of Psychiatry. 152(4). 579–582. 94 indexed citations

11.

Nierenberg, A A, Katharine A. Phillips, Lisa A. Uebelacker, et al.. (1995). Body dysmorphic disorder is comorbid with major depression. Biological Psychiatry. 37(9). 611–611. 2 indexed citations

12.

Renshaw, Perry F., A. R. Guimaraes, M. Fava, et al.. (1992). Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. American Journal of Psychiatry. 149(11). 1592–1594. 66 indexed citations

13.

Fava, M., Karen E. Anderson, & Jerrold F. Rosenbaum. (1990). "Anger attacks": possible variants of panic and major depressive disorders. American Journal of Psychiatry. 147(7). 867–870. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact